Realtime-Estimate
Andere Börsenplätze
|
% 5 Tage | % 1. Jan. | ||
1.675 USD | +5.35% | -21.50% | -12.78% |
Kurzporträt
Mitarbeiterzahl: 143
Manager
Manager | Titel | Alter | Seit |
---|---|---|---|
Aya Jakobovits
FOU | Founder | 71 | 01.11.14 |
Chen Schor
CEO | Chief Executive Officer | 51 | 01.07.16 |
Brian Harvey
DFI | Director of Finance/CFO | 63 | 01.09.20 |
Blake Aftab
CTO | Chief Tech/Sci/R&D Officer | 43 | 13.04.21 |
Francesco Galimi
CTO | Chief Tech/Sci/R&D Officer | 56 | 01.09.19 |
Donald Healey
CTO | Chief Tech/Sci/R&D Officer | 62 | 26.10.20 |
Anne Bowdidge
IRC | Investor Relations Contact | - | - |
Amy Locke
HRO | Human Resources Officer | - | 01.02.22 |
Nancy L. Boman
LAW | General Counsel | - | 29.11.22 |
Aufsichtsräte
Aufsichtsräte | Titel | Alter | Seit |
---|---|---|---|
Steve Dubin
BRD | Director/Board Member | 70 | 15.09.20 |
Carl Gordon
CHM | Chairman | 59 | 15.08.15 |
Michael Kauffman
BRD | Director/Board Member | 60 | 17.11.21 |
Chen Schor
CEO | Chief Executive Officer | 51 | 01.07.16 |
Aya Jakobovits
FOU | Founder | 71 | 01.11.14 |
Andrew Sinclair
BRD | Director/Board Member | 52 | 02.03.21 |
Director/Board Member | 68 | 15.09.20 | |
Katie Peng
BRD | Director/Board Member | - | 10.07.23 |
Anteilsklasse
Vote | Menge | Streubesitz | Konzerneigene Aktien | Total Float | |
---|---|---|---|---|---|
Aktie A | 1 | 82 169 603 | 81 000 664 ( 98,58 %) | 0 | 98,58 % |
Unternehmenskontakt
Sektor
Verlauf des Gewinns je Aktie
% 1. Jan. | Kap. | |
---|---|---|
-12.78% | 131 Mio. | |
+1.28% | 42.86 Mrd. | |
+11.58% | 42.74 Mrd. | |
+45.26% | 41.36 Mrd. | |
-8.83% | 27.68 Mrd. | |
+7.57% | 25.15 Mrd. | |
-22.95% | 18.63 Mrd. | |
+29.69% | 12.37 Mrd. | |
-2.44% | 11.92 Mrd. | |
+7.57% | 11.21 Mrd. |
- Börse
- Aktien
- A2QESQ Aktie
- Unternehmen Adicet Bio, Inc.